TNF and HIV infectious disease: Indeed, individuals with HIV infection or hematologic malignancies, those undergoing solid organ or hematopoietic cell transplantation, or receiving immunosuppressive treatments (e.g., chemotherapy, glucocorticoids, and anti-tumor necrosis factor alpha (TNF-α) therapy) are at high risk of developing severe and/or complicated diseases [2].